Intervention to Preserve Beta-Cell Function in GAD Ab-Positive Diabetes
NCT00232375
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
42
Enrollment
OTHER
Sponsor class
Conditions
GAD Ab Positive Clinically Type 2 Diabetic Patients
Interventions
DRUG:
Insulin
Sponsor
Tokyo Study Group